Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 9 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Jan. 31, 2017
Jan. 31, 2016
Income Statement [Abstract]        
Revenues $ 3,735,626 $ 2,164,031 $ 9,957,467 $ 5,783,053
Operating expenses        
Cost of revenues (exclusive of depreciation and amortization shown separately below) 1,359,131 995,526 3,490,046 2,637,436
General and administrative 2,133,074 1,659,133 6,228,554 4,746,953
Program review expense 25,000 25,000  
Depreciation and amortization 132,727 151,597 422,782 443,314
Total operating expenses 3,649,932 2,806,256 10,166,382 7,827,703
Operating income (loss) 85,694 (642,225) (208,915) (2,044,650)
Other income (expense):        
Other income 1,684 1,414 3,047 8,077
Interest expense (80,001) (34,153) (175,662) (101,518)
Total other expense, net (78,317) (32,739) (172,615) (93,441)
Income (loss) before income taxes 7,377 (674,964) (381,530) (2,138,091)
Income tax expense (benefit)
Net income (loss) $ 7,377 $ (674,964) $ (381,530) $ (2,138,091)
Net income (loss) per share allocable to common stockholders - basic $ 0.00 $ (0.06) $ (0.03) $ (0.20)
Net income (loss) per share allocable to common stockholders - diluted $ 0.00 $ (0.06) $ (0.03) $ (0.20)
Weighted average number of common shares outstanding: basic 11,467,345 10,694,730 11,419,270 10,689,300
Weighted average number of common shares outstanding: diluted 13,040,970 10,694,730 11,419,270 10,689,300